Enhancing Memory in Mild Cognitive Impairment and Early Stage Alzheimer's Disease

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 7, 2021

Primary Completion Date

April 30, 2023

Study Completion Date

April 30, 2023

Conditions

Alzheimer DiseaseMild Cognitive Impairment

Interventions

DEVICE

North Coast Medical Activadose II

tES device model Activadose II (North Coast Medical, Morgan Hill, CA, USA) programed to deliver tES.

Trial Locations (1)

Mind Research Network, Albuquerque

All Listed Sponsors

lead

The Mind Research Network

OTHER

NCT05077826 - Enhancing Memory in Mild Cognitive Impairment and Early Stage Alzheimer's Disease | Biotech Hunter | Biotech Hunter